These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 11161128)

  • 1. Gamma butyrolactone (GBL) withdrawal syndromes.
    Catalano MC; Glass JM; Catalano G; Burrows SL; Lynn WA; Weitzner BS
    Psychosomatics; 2001; 42(1):83-8. PubMed ID: 11161128
    [No Abstract]   [Full Text] [Related]  

  • 2. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.
    McDaniel CH; Miotto KA
    J Psychoactive Drugs; 2001; 33(2):143-9. PubMed ID: 11476261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management and treatment of gamma butyrolactone withdrawal syndrome: a case report and review.
    Ghio L; Cervetti A; Respino M; Belvederi Murri M; Amore M
    J Psychiatr Pract; 2014 Jul; 20(4):294-300. PubMed ID: 25036586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pentobarbital for severe gamma-butyrolactone withdrawal.
    Sivilotti ML; Burns MJ; Aaron CK; Greenberg MJ
    Ann Emerg Med; 2001 Dec; 38(6):660-5. PubMed ID: 11719746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gamma-butyrolactone (GBL) dependence and withdrawal.
    Bell J; Collins R
    Addiction; 2011 Feb; 106(2):442-7. PubMed ID: 20925687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 16-year-old boy with severe gamma-butyrolactone (GBL) withdrawal delirium.
    Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Wagner A; Poustka F; Wöckel L
    Pharmacopsychiatry; 2009 Sep; 42(5):202-3. PubMed ID: 19724983
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome-like reaction precipitated by antipsychotics in a patient with gamma-butyrolactone withdrawal.
    Eiden C; Capdevielle D; Deddouche C; Boulenger JP; Blayac JP; Peyrière H
    J Addict Med; 2011 Dec; 5(4):302-3. PubMed ID: 21817917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of a young adult taking gamma-butyrolactone (GBL) in a primary care clinic.
    Herold AH; Sneed KB
    J Am Board Fam Pract; 2002; 15(2):161-3. PubMed ID: 12002201
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation for the withdrawal syndrome from gamma-hydroxybutyric acid (GHB), gamma-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines.
    Quang LS; Colombo G; Lobina C; Maccioni P; Orru A; Gessa GL; Maher TJ; Carai MA
    Ann N Y Acad Sci; 2006 Aug; 1074():545-58. PubMed ID: 17105952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusual presentation of a patient with GBL withdrawal: a case report.
    Kashyap GL; Patel AG
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S32-4. PubMed ID: 21894099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe delirium of uncertain origin in a german psychiatric unit - caused by gamma-butyrolactone withdrawal.
    Hohl-Radke F; Voss M; Staedt J
    Pharmacopsychiatry; 2008 Sep; 41(5):200-1. PubMed ID: 18763223
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychiatric aspects of acute withdrawal from gamma-hydroxybutyrate (GHB) and its analogue gamma-butyrolactone (GBL): implications for psychiatry services in the general hospital.
    Choudhuri D; Cross S; Dargan PI; Wood DM; Ranjith G
    Int J Psychiatry Clin Pract; 2013 Jun; 17(2):154-6. PubMed ID: 23485126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intoxications due to ingestion of gamma-butyrolactone: organ distribution of gamma-hydroxybutyric acid and gamma-butyrolactone.
    Lenz D; Rothschild MA; Kröner L
    Ther Drug Monit; 2008 Dec; 30(6):755-61. PubMed ID: 18824955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of withdrawal from the GHB precursors gamma-butyrolactone and 1,4-butanediol.
    Schneir AB; Ly BT; Clark RF
    J Emerg Med; 2001 Jul; 21(1):31-3. PubMed ID: 11399385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acute gamma-butyrolactone poisoning with withdrawal syndrome].
    Chwaluk P; Rejmak G
    Przegl Lek; 2011; 68(8):537-8. PubMed ID: 22010460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of severe withdrawal from gamma-hydroxybutyrate.
    Chin RL
    Ann Emerg Med; 2001 May; 37(5):551-2. PubMed ID: 11326198
    [No Abstract]   [Full Text] [Related]  

  • 17. ["Liquid ecstasy": gamma-butyrolactone withdrawal delirium with rhabdomyolysis and dialysis dependent renal failure].
    Supady A; Schwab T; Busch HJ
    Dtsch Med Wochenschr; 2009 Apr; 134(18):935-7. PubMed ID: 19384813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenmetrazine psychoses.
    Jaroszyński J; Spasowicz E; Ulasińska-Rubach D
    Pol Med J; 1971; 10(1):253-7. PubMed ID: 5573909
    [No Abstract]   [Full Text] [Related]  

  • 19. Withdrawal, recovery, and long-term sequelae of gamma-butyrolactone dependence: a case report.
    Henderson DL; Ginsberg JP
    Am J Addict; 2008; 17(5):456-7. PubMed ID: 18770093
    [No Abstract]   [Full Text] [Related]  

  • 20. A case of γ-butyrolactone associated with severe withdrawal delirium and acute renal failure.
    Bhattacharya IS; Watson F; Bruce M
    Eur Addict Res; 2011; 17(4):169-71. PubMed ID: 21454980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.